Duclos P
Division de l'immunisation des enfants. Bureau de l'épidémiologie des maladies transmissibles, Ottawa, Ontario, Canada.
Rev Epidemiol Sante Publique. 1994;42(5):425-33.
Despite a continuous search for safer and more efficacious vaccines, adverse events continue to occur following vaccine administration. Adverse events are usually mild. Serious adverse events that could result in death or permanent sequelae are extremely rare. In all cases, benefits associated with immunization greatly outweigh the risks. Due to the large number of doses administered, it is probable that there are purely temporal associations between some adverse events and vaccine administration. Since immunization is sometimes mandatory with vaccines usually administered to healthy individuals and their benefits expanded to the community at large, adverse events are difficult to accept. Primary objectives of vaccine-associated adverse events surveillance is the early detection and appropriate and quick response to such events in order to lessen the negative impact on immunization programs and on the health of the individuals. Specific aspects of vaccine postmarketing surveillance are presented.
尽管一直在寻找更安全、更有效的疫苗,但接种疫苗后仍会出现不良事件。不良事件通常较为轻微。可能导致死亡或永久性后遗症的严重不良事件极为罕见。在所有情况下,免疫接种带来的益处都远远超过风险。由于接种剂量巨大,某些不良事件与疫苗接种之间可能纯粹只是时间上的关联。鉴于对健康个体接种的疫苗有时是强制性的,且其益处惠及整个社区,不良事件难以被接受。疫苗相关不良事件监测的主要目标是尽早发现此类事件并做出恰当、迅速的应对,以减轻对免疫规划和个体健康的负面影响。本文介绍了疫苗上市后监测的具体方面。